Since IL-1Ra and MCP-1 levels were significantly higher in placebo recipients than CYD-TDV recipients in our study, and both are soluble mediators associated with increased dengue severity, this is a positive finding regarding a potential risk linked to the vaccine. The gene discussed is CCL2; the disease is dengue disease.